Difficulty: Medium
Average Score: 73%
Practice
A 62-year-old retired small business owner has had slowly increasing intraocular pressure bilaterally. You start him on drug used to treat his open-angle glaucoma, which also happens to cross the blood├óÔé¼ÔÇ£brain barrier better than other drugs in its class. Which of the following drugs is this?
Correct answer
D
Rationale
The correct answer is D) Physostigmine. Physostigmine is a cholinesterase inhibitor that can effectively lower intraocular pressure in open-angle glaucoma. Unlike the other options, physostigmine is known to cross the blood-brain barrier better due to its tertiary amine structure, allowing it to have effects in the central nervous system as well.
A) Echothiophate is an irreversible cholinesterase inhibitor used topically to treat glaucoma but does not have significant blood-brain barrier penetration.
B) Edrophonium is a short-acting cholinesterase inhibitor used for diagnostic purposes in myasthenia gravis and does not have significant blood-brain barrier penetration.
C) Neostigmine is a cholinesterase inhibitor primarily used to treat myasthenia gravis and postoperative ileus, with minimal central nervous system effects due to poor blood-brain barrier penetration.
Understanding the pharmacokinetic properties of CNS drugs is crucial for healthcare professionals to make informed decisions when selecting appropriate treatments for patients. Physostigmine's ability to cross the blood-brain barrier makes it a valuable option for conditions where central nervous system effects are desired.
A) Echothiophate is an irreversible cholinesterase inhibitor used topically to treat glaucoma but does not have significant blood-brain barrier penetration.
B) Edrophonium is a short-acting cholinesterase inhibitor used for diagnostic purposes in myasthenia gravis and does not have significant blood-brain barrier penetration.
C) Neostigmine is a cholinesterase inhibitor primarily used to treat myasthenia gravis and postoperative ileus, with minimal central nervous system effects due to poor blood-brain barrier penetration.
Understanding the pharmacokinetic properties of CNS drugs is crucial for healthcare professionals to make informed decisions when selecting appropriate treatments for patients. Physostigmine's ability to cross the blood-brain barrier makes it a valuable option for conditions where central nervous system effects are desired.